AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate in Rwanda
2 products registered with RDA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Dolutegravir, Lamivudine and Tenofovir Disoproxil Fumarate Tablets | Rwanda FDA-HMP-MA-2112 | MICRO LABS LIMITED | active | 17 Oct 2029 |
| DOLUTEGRAVIR, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE TABLET 50MG,300MG & 300MG TABLETS | Rwanda FDA-HMP-MA-1936 | LUPIN Limited | active | 16 Aug 2029 |
Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate — RDA Registration Details
RDA (Rwanda) has 2 registered products containing Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate, of which 2 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track Dolutegravir, Lamivudine And Tenofovir Disoproxil Fumarate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.